{"id":"NCT02458287","sponsor":"Pfizer","briefTitle":"Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia","officialTitle":"A 12 Week, Phase 3, Double-blind, Randomized, Placebo-controlled, Parallel Group Study To Assess The Efficacy, Safety, Tolerability And Actual Use Of Bococizumab And An Autoinjector (Pre-filled Pen) In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06","primaryCompletion":"2016-02","completion":"2016-02","firstPosted":"2015-06-01","resultsPosted":"2017-12-19","lastUpdate":"2017-12-19"},"enrollment":299,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperlipidemia"],"interventions":[{"type":"BIOLOGICAL","name":"Bococizumab 150mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Bococizumab 75mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Bococizumab 150mg placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Bococizumab 75mg placebo","otherNames":[]}],"arms":[{"label":"Bococizumab 150mg","type":"EXPERIMENTAL"},{"label":"Bococizumab 75mg","type":"EXPERIMENTAL"},{"label":"Bococizumab 150mg placebo","type":"PLACEBO_COMPARATOR"},{"label":"Bococizumab 75mg placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is a multicenter, randomized study in subjects with high cholesterol receiving statins to assess the efficacy to lower LDL-C, the safety, tolerability and actual use of bococizumab and an autoinjector (pre-filled pen).","primaryOutcome":{"measure":"Percent Change From Baseline at Week 12 in Fasting Low Density Lipoprotein Cholesterol (LDL-C) Level for Bococizumab 150 mg Dose Group and Matched Placebo","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Placebo Matched to Bococizumab 150 mg","deltaMin":6.2,"sd":3.57},{"arm":"Bococizumab 150 mg","deltaMin":-57.2,"sd":2.57}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":["28304227"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1481046&StudyName=A%2012%20Week%2C%20Phase%203%2C%20Double-blind%2C%20Randomized%2C%20Placebo-controlled%2C%20Parallel%20Group%20Study%20To%20Assess%20The%20Efficacy%2C%20Safety%2C%20Tolerability%20And%20Actual%20Use%20Of%20Bococizumab%20And%20An%20Autoinjector%20%28pre-filled%20Pen%29%20In%20Subjects%20With%20Primary%20Hyperlipidemia%20Or%20Mixed%20Dyslipidemia"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["Upper respiratory tract infection","Diarrhoea","Nasopharyngitis"]}}